ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000232600.2	ABT-263 (navitoclax)	Esophageal cancer	0.0043779	Sensitive
ENSG00000232600.2	ABT-263 (navitoclax)	Pancreatic adenocarcinoma	0.032167419	Sensitive